LC-ESI-MS/MS analysis and pharmacokinetics of GP205, an innovative potent macrocyclic inhibitor of hepatitis C virus NS3/4A protease in rats

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Nan YangGuorong Fan

Abstract

A high-throughput, sensitive and specific LC-ESI-MS/MS method was established for the quantitative determination of GP205, a potent inhibitor of hepatitis C virus NS3/4A protease, in rat. The analyte was isolated from 25 μL plasma sample by 96-well LLE. Good linearity was achieved within the concentration range of 2-5000 ng/mL (r2 > 0.996). The intra- and inter-day precision was less than 10%. The accuracy ranged from 0.8% to 5.5% for GP205 in quality control samples at three levels. GP205 was stable during the analysis and the storage period. The method was successfully applied to pharmacokinetic studies of GP205 in Sprague-Dawley rats. The pharmacokinetic profiles of GP205 at three dose levels with oral administration and one dose level with intravenous administration were successfully studied for the first time in SD rats, respectively. After single oral administration of GP205 at the doses of 2.5, 5, 10 mg/kg, respectively, Cmax and AUC0-τ were proportional to the doses given. The absolute bioavailability was estimated as 34% based on the AUCs of oral administration at the dose of 5 mg/kg and intravenous administration at the dose of 1 mg/kg. The data presented in this study provides useful information for further study for...Continue Reading

References

Jul 15, 2000·Seminars in Liver Disease·A Wasley, M J Alter
Mar 6, 2002·Journal of Viral Hepatitis·M I Memon, M A Memon
Oct 10, 2002·Bioorganic & Medicinal Chemistry Letters·E Scott PriestleyCarl P Decicco
Jan 31, 2003·Expert Opinion on Investigational Drugs·Frank NarjesChristian Steinkühler
Dec 20, 2003·Bioorganic & Medicinal Chemistry Letters·Jason LamarShu-Hui Chen
Mar 5, 2004·Annals of Internal Medicine·Stephanos J HadziyannisUNKNOWN PEGASYS International Study Group
Mar 31, 2004·Bioorganic & Medicinal Chemistry Letters·Robert B PerniJohn A Thomson
Apr 15, 2004·Bioorganic & Medicinal Chemistry Letters·Emanuela NiziCristina Gardelli
Oct 28, 2004·Gastroenterology·T Jake Liang, Theo Heller
Jan 7, 2005·Journal of Medicinal Chemistry·Christopher P Gordon, Paul A Keller
Feb 26, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Markus ReiserGerhard G Steinmann
Aug 19, 2005·Nature·Raffaele De Francesco, Giovanni Migliaccio
Jul 13, 2007·The New England Journal of Medicine·Mitchell L ShiffmanUNKNOWN ACCELERATE Investigators
Jul 14, 2007·Current Topics in Medicinal Chemistry·Uwe Koch, Frank Narjes
Dec 1, 2007·Nature Reviews. Drug Discovery·Michael P MannsMichael Houghton
Mar 15, 2008·Journal of the American Chemical Society·Nigel J LivertonJoseph P Vacca
Oct 1, 2008·Antimicrobial Agents and Chemotherapy·Scott D SeiwertLawrence M Blatt
Dec 17, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Norman M KnetemanMarc Collett
Feb 12, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Daniel Lavanchy
May 1, 2009·The New England Journal of Medicine·Christophe HézodeUNKNOWN PROVE2 Study Team
Oct 21, 2009·Antimicrobial Agents and Chemotherapy·Nigel J LivertonJoseph P Vacca
Feb 19, 2010·Journal of Medicinal Chemistry·John A McCauleyNigel J Liverton
Jun 29, 2010·Journal of Hepatology·Ralf BartenschlagerVolker Lohmann
Nov 26, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D Lavanchy
Feb 15, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jennifer J KiserGregory T Everson
Jun 5, 2012·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Fumitaka SuzukiHiromitsu Kumada
Jul 28, 2013·Advances in Pharmacology·Jean-Michel Pawlotsky
Oct 2, 2013·Expert Opinion on Drug Metabolism & Toxicology·Hari ShankarDouglas T Dieterich
Jun 8, 2014·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Ana Cláudia de OliveiraEdison Roberto Parise

❮ Previous
Next ❯

Software Mentioned

Varian MS workstation

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.